ROCKVILLE, Md. (WJZ) — Novavax gave an update Monday on its COVID-19 vaccine clinical development progress.
The Maryland-based company said its Phase Three Trial is expected to begin in the U.S. and Mexico in the coming weeks.
- Coronavirus Resources: How To Get Help In Maryland
- TIMELINE: Coronavirus In Maryland, Tracking The Spread
- Latest coronavirus stories from WJZ
- Latest CDC Guidelines
Enrollment for the Phase Three trial in the United Kingdom is complete.
Novavax was awarded $1.6 billion from the U.S. government to meet its Operation Warp Speed to expediate delivery of millions of doses of its vaccine once approved.